COPS6 and familial pancreatic carcinoma: To elucidate the molecular mechanism by which CSN6 promotes pancreatic cancer progression, we performed quantitative proteomic analysis (LC‐MS) using PANC‐1 cells treated with either shSC (Scramble) or shCSN6 (Figure S3A, Supporting Information).